PBI75 REVIEW OF ECONOMIC EVALUATIONS FOR GENE THERAPIES:ARE WE READY FOR THE FUTURE?

High prices asked upfront for novel one-off gene therapies accompanied by uncertain long-term value claims raise concerns around reimbursement and affordability for Health Technology Assessments (HTAs) and payers. Economic evaluations (EEs) are commonly used to inform these reimbursement decisions. This study aimed to examine economic evaluation studies of Gene Therapies (GTs) and to provide an overview of the quality of the economic evidence...